D-0889-2022 Class II Ongoing

Recalled by Noven Pharmaceuticals Inc — Miami, FL

FDA drug recall D-0889-2022 was initiated by Noven Pharmaceuticals Inc on May 6, 2022 and is designated Class II. Reason for recall: Defective Delivery System: customer complaints exceeded respective action limits. The recall status is ongoing. Affected quantity: 274, 110 patches.

Recall details

Product Type
Drugs
Report Date
Jun 1, 2022
Initiation Date
May 6, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
274, 110 patches

Product description

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3

Reason for recall

Defective Delivery System: customer complaints exceeded respective action limits.

Distribution pattern

Nationwide to the U.S. Market

Code information

Lot: 90764 Exp. 08/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0889-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0889-2022. Report a data issue: hello@regdatalab.com.